Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
cyclobenzaprine | aldehyde oxidase | small molecule | NA | drugbank | Spinal Cord Diseases[MeSHID:D013118] Spasm[MeSHID:D013035] Fibromyalgia[MeSHID:D005356] Cerebral Palsy[MeSHID:D002547] Muscle Spasticity[MeSHID:D009128] Sleep Disorders[MeSHID:D012893] Rheumatism[MeSHID:D012216] Off-Label Use[MeSHID:D056687] Pain[MeSHID:D010146] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | inhibitor |
cyclobenzaprine | 5-hydroxytryptamine receptor 2a | small molecule | NA | drugbank , DGIDB | Spinal Cord Diseases[MeSHID:D013118] Spasm[MeSHID:D013035] Fibromyalgia[MeSHID:D005356] Cerebral Palsy[MeSHID:D002547] Muscle Spasticity[MeSHID:D009128] Sleep Disorders[MeSHID:D012893] Rheumatism[MeSHID:D012216] Off-Label Use[MeSHID:D056687] Pain[MeSHID:D010146] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
0.52 | approved | antagonist |
cyclobenzaprine | 5-hydroxytryptamine receptor 2b | small molecule | NA | drugbank | Spinal Cord Diseases[MeSHID:D013118] Spasm[MeSHID:D013035] Fibromyalgia[MeSHID:D005356] Cerebral Palsy[MeSHID:D002547] Muscle Spasticity[MeSHID:D009128] Sleep Disorders[MeSHID:D012893] Rheumatism[MeSHID:D012216] Off-Label Use[MeSHID:D056687] Pain[MeSHID:D010146] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | antagonist |
cyclobenzaprine | 5-hydroxytryptamine receptor 2c | small molecule | NA | drugbank | Spinal Cord Diseases[MeSHID:D013118] Spasm[MeSHID:D013035] Fibromyalgia[MeSHID:D005356] Cerebral Palsy[MeSHID:D002547] Muscle Spasticity[MeSHID:D009128] Sleep Disorders[MeSHID:D012893] Rheumatism[MeSHID:D012216] Off-Label Use[MeSHID:D056687] Pain[MeSHID:D010146] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | antagonist |
cyclobenzaprine | 5-hydroxytryptamine receptor 6 | small molecule | NA | drugbank | Spinal Cord Diseases[MeSHID:D013118] Spasm[MeSHID:D013035] Fibromyalgia[MeSHID:D005356] Cerebral Palsy[MeSHID:D002547] Muscle Spasticity[MeSHID:D009128] Sleep Disorders[MeSHID:D012893] Rheumatism[MeSHID:D012216] Off-Label Use[MeSHID:D056687] Pain[MeSHID:D010146] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | antagonist |
cyclobenzaprine | 5-hydroxytryptamine receptor 7 | small molecule | NA | drugbank | Spinal Cord Diseases[MeSHID:D013118] Spasm[MeSHID:D013035] Fibromyalgia[MeSHID:D005356] Cerebral Palsy[MeSHID:D002547] Muscle Spasticity[MeSHID:D009128] Sleep Disorders[MeSHID:D012893] Rheumatism[MeSHID:D012216] Off-Label Use[MeSHID:D056687] Pain[MeSHID:D010146] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | antagonist |
cyclobenzaprine | sodium-dependent noradrenaline transporter | small molecule | NA | drugbank | Spinal Cord Diseases[MeSHID:D013118] Spasm[MeSHID:D013035] Fibromyalgia[MeSHID:D005356] Cerebral Palsy[MeSHID:D002547] Muscle Spasticity[MeSHID:D009128] Sleep Disorders[MeSHID:D012893] Rheumatism[MeSHID:D012216] Off-Label Use[MeSHID:D056687] Pain[MeSHID:D010146] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | inhibitor |
cyclobenzaprine | sodium-dependent serotonin transporter | small molecule | NA | drugbank | Spinal Cord Diseases[MeSHID:D013118] Spasm[MeSHID:D013035] Fibromyalgia[MeSHID:D005356] Cerebral Palsy[MeSHID:D002547] Muscle Spasticity[MeSHID:D009128] Sleep Disorders[MeSHID:D012893] Rheumatism[MeSHID:D012216] Off-Label Use[MeSHID:D056687] Pain[MeSHID:D010146] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | inhibitor |
cyclobenzaprine | toll-like receptor 4 | small molecule | NA | drugbank | Spinal Cord Diseases[MeSHID:D013118] Spasm[MeSHID:D013035] Fibromyalgia[MeSHID:D005356] Cerebral Palsy[MeSHID:D002547] Muscle Spasticity[MeSHID:D009128] Sleep Disorders[MeSHID:D012893] Rheumatism[MeSHID:D012216] Off-Label Use[MeSHID:D056687] Pain[MeSHID:D010146] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] |
NA | approved | inhibitor |
click here to return to the previous page |